A life sciences company based out of a Purdue University professor’s lab has received a nearly $975,000 Small Business Innovation Research grant from the National Science Foundation. GeniPhys says it will use the two-year grant to scale up manufacturing capabilities to commercialize its initial product.... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is reporting a drop in both full-year and fourth quarter net income. The CEO sees growth.... Read More
life sciences industry saw strong growth last year, particularly in the pharmaceutical and medical device sectors. The state's life sciences initiative says 23 companies committed to invest more than $500 million and add 2,100 employees in Indiana. ... Read More
Industry experts say Indiana is emerging as a powerful hub for nuclear medicine, and the most recent fuel to be added to the fire is Telix Pharmaceuticals earning approval from the U.S. Food and Drug Administration to launch its first commercial product. The radiopharmaceuticals sector, also known as nuclear medicine, is gathering momentum in central […]... Read More
A recent DNA discovery means four Hoosier high school students are published scientists at the young age of 18. While COVID wreaked havoc on students’ senior years, Noblesville High School teacher Caitlyn Foye got creative with the closures and brought cutting-edge research to her classroom. The students uncovered four new gene sequences—a discovery so rare […]... Read More
Triple negative breast cancer (TNBC) is a devastating form of breast cancer that has left researchers scrambling to find weapons against its high recurrence rate, lower survival rate than other forms of the disease and confusion about how to best treat it—and Indiana is leading the charge. As a nerve center for TNBC research, the […]... Read More
In the same way that precision medicine has revolutionized the treatment of cancer, it could also radically improve how patients are treated for depression, says Carmel-based startup Gate Neurosciences Inc. In oncology, precision medicine enables doctors to analyze the biology of the patient’s tumor, then prescribe drugs that are most powerful against that specific type […]... Read More
An Ohio-based medical supply company has announced plans to develop a medical logistics and distribution center in Greenwood, if it can get a tax break from the city. ... Read More
Indiana University’s Public Policy Institute is estimating the Cook Medical manufacturing facility under construction on the northeast side of Indianapolis will have an economic impact of nearly $26 million annually for Marion County.... Read More
An Indianapolis-based home healthcare equipment provider will soon be under new ownership less than a year after going public. Virginia-based Owens & Minor Inc. (NYSE: OMI) has entered into a definitive agreement to acquire Apria Inc. (Nasdaq: APR) in a deal valued at $1.6 billion. Owens & Minor says the acquisition will position the company as a leader in the home healthcare market.... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research and collaboration agreement with Entos Pharmaceuticals in Canada. Lilly says the deal will support the development of therapies for multiple neurologic conditions.... Read More
A Hoosier biopharmaceutical contract development and manufacturing organization will soon be under new ownership. Germany-based Merck KGaA has announced plans to acquire Exelead, headquartered in Indianapolis, in a $780 million deal. Merck ... Read More
The U.S. Department of Health and Human Services has paused the distribution of COVID-19 antibody therapies developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY), as well as one from another pharmaceutical company. The agency cites new data that shows the therapies are unlikely to be effective against the Omicron variant.... Read More
The U.S. Food and Drug Administration has granted an Emergency Use Authorization for a COVID-19 At-Home Test developed by Roche Diagnostics. The company says the test will be available across the country beginning in January.... Read More
An Australian pharmaceutical company with a major presence in central Indiana has hit a major milestone. Telix Pharmaceuticals Inc., which has its U.S. headquarters in Fishers, has received approval from the U.S. Food and Drug Administration for its lead prostate cancer imaging product.... Read More
A biotechnology company headquartered in France has chosen central Indiana for its second U.S.-based manufacturing facility. Orano Med plans to initially invest more than $15 million to build the facility and create a dozen jobs.... Read More
After more than a decade of work, Purdue University-based On Target Laboratories Inc. has claimed the “holy grail” of biotech startups; just days ago, the U.S. Food and Drug Administration approved CYTALUX, a surgical innovation for cervical cancer from the lab of Purdue’s Dr. Philip Low, who has launched seven companies and sold Endocyte for […]... Read More
A new material invented by a professor at the University of Notre Dame for spinal implants is likely just months away from being used on the first patients. Implants used for spinal fusion have long been made out of a polymer called PEEK, because it’s “a good material” with excellent mechanical properties, says Notre Dame […]... Read More
The biggest vaccination campaign in history is creating new pressures in logistics, and an Indianapolis-based company is responding by building a distribution facility designed specifically for the shifting demands of the life sciences industry. Langham Logistics says the new distribution center—the company’s first one north of Indianapolis—will also support a recent explosion of life sciences […]... Read More
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) is reporting fiscal full-year net income of $10.9 million, compared to a loss of $4.7 million the previous year. Chief Executive Officer Robert Leasure says the transformational year reflected the company's success in "expanding existing operations and services, starting up new services, and acquiring strategic assets."... Read More
